Facing The Challenges of Systemic Therapy Selection for Psoriasis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Brad Glick, DO, dermatologist and residency program director at Larkin Health Center in South Florida, to discuss the complexities of selecting systemic therapies for psoriasis. They share insights on navigating the abundance of treatment options, focusing on patient-centric considerations, with an emphasis on the TYK2 inhibitor deucravacitinib.
They begin by highlighting how treatment selection often depends more on disease location and patient impact than on body surface area alone and discuss the importance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.